Conclusion: Several inhaled insulin products are under development ... [1] Depending on the severity of the disease, patients often require three or more insulin injections daily to control ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

Doctors battling diabetes across the Middle East have welcomed the decision by the Ministry of Health (MOH) in the UAE to approve the registration of an insulin inhalation treatment seen as a ...

Inhaled insulin is contraindicated in patients with active lung cancer or chronic lung disease, such as asthma or chronic obstructive pulmonary disease (COPD). Studies suggest that there might be ...

I am once again making MannKind Corp. (MNKD) my "Top Pick" for more aggressive investors in 2025, advises Nate Pile, editor of Nate’s Notes.

However, the market for all inhalation-related diseases, specifically idiopathic ... not hindered by the withdrawal of the first inhaled insulin, Exubera, in 2007. In fact over the past four ...

MannKind Co. (NASDAQ:MNKD – Get Free Report) has received a consensus rating of “Buy” from the eight brokerages that are ...

Given the positive effects of granting more prescription authority, it is unsurprising that the number of pharmacists ...

Health care is notoriously more difficult to provide for rural communities than urban ones. Rural Americans are less likely ...

Given the positive effects of granting more prescription authority, it is unsurprising that the number of pharmacists ...

US President Donald Trump literally lives on 12 cans of diet cola beverage daily, along with the staples of McDonald's and Wendy’s. While it is a lot of soda to consume in one day, studies say the ...